Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(CSE:XPHY)

N/A UNCHANGED
Last Price Updated: 3:47 PM EST, Nov 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about XPHY

< Previous 1 2 3 Next >
XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event
Via Investor Brand Network
XPhyto Announces Managing Director Appointment, Financing and 3a-diagnostics Development
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / November 3, 2021 / XPhyto Therapeutics Corp.... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Shares Drug-Development Update
Via Investor Brand Network
XPhyto Reports Development Update for its Drug Delivery Business
- Rotigotine transdermal skin patch optimization and pivotal study planning underway - Rotigotine patch manufacturing, sales and marketing in preparation - Cannabinoid oral dissolvable film (ODF)... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
InvestorNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Extends Agreements with Partners
Via Investor Brand Network
Xphyto Announces Engagement of Consultants for Marketing and Promotional Activities
VANCOUVER, BC / ACCESSWIRE / October 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the"Company") announces it has entered into extensions to investor relations... 
From XPhyto Therapeutics Corp.
Via AccessWire
XPhyto Reports Successful Market Launch and Growing Demand for its 25-minute COVID-19 PCR Test COVID-ID Lab
VANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / September 8, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the successful... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
XPhyto Launches First Commercial Biosensor for Oral Disease
- Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutes - Easy and simple at-home self-checks improve oral health and indicate... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Senators, Feds Discuss Cannabis Legalization During Drug Overdose Hearing
Via CannabisNewsWire
Topics Cannabis Death
Exposures Cannabis Death
XPhyto’s Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates
- First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto's oral dissolvable delivery platform - Biosensor candidates are ready for optimization and... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — Three Tips for New Medical Cannabis Patients
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Signs Transformative Acquisition Agreement With 3a-Diagnostics, to Enter Hi-Tech Biosensor Market and Expand Its Diagnostic Product Portfolio
- The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products. - The acquisition... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures COVID-19 Cannabis Intellectual Property
420 with CNW — Federal Economic Committee Recommends Marijuana Reclassification as Industry Continues to Grow
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Study Finds That Marijuana Possesses Strain-Specific Effect on Driving Performance
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Announces Advertising Agreement with Agora Internet Relations Corp.
VANCOUVER, BC / ACCESSWIRE / July 2, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces that pursuant to its advertising agreement with AGORA... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
XPhyto Supplies 10 Test Centers in Berlin with 25-minute COVID-19 PCR Test
- XPhyto signs master supply agreement with operator of 10 COVID-19 test centers - The test will be offered to customers as a rapid PCR test with sample processing on site - Commercial operations... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — California Earmarks $100M to Support Licensed Cannabis Firms During Pandemic
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
420 with CNW — Medical Marijuana Activists in Pennsylvania See Workers’ Comp. Decision as a Win
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Congressional Bill Could Enable Researchers to Study Cannabis from Dispensaries
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Study Finds That CBD May Improve Overall Wellness
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Provides Progress Report on Mescaline Program for Psychedelic Therapies
- Research and development lab set up, preliminary mescaline synthesis complete - Modified synthesis process developed, mescaline batches manufactured - Development of analytical methods and... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
420 with CNW — Cannabis Prohibition Costs $53 Billion Annually in the US
Via CannabisNewsWire
Topics Cannabis Economy
Exposures COVID-19 Cannabis Economy
420 with CNW — How the State of New York Plans to Tax Marijuana
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Rapid Point-of-Care COVID-19 PCR Test Offered for Sale in Germany
- Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021 - Volume based pricing competitive with other COVID-19 PCR test products on the market -... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — Everything You Need to Know About Delta-8 THC
Via CannabisNewsWire
Topics Cannabis Derivatives
Exposures Cannabis Derivatives
XPhyto Provides Update on Drug Formulation and Development Business
- Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal study - Land purchased for construction of commercial drug manufacturing facility in Germany VANCOUVER,... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures Cannabis
420 with CNW — Texas House Approves Bill to Reduce Criminal Penalties for Cannabis Possession
Via CannabisNewsWire
Topics Cannabis
Exposures Cannabis
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
- Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logistics - Project is in cooperation with a German pharmacy currently running a COVID-19 test... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
420 with CNW — Ways Marijuana Extraction Companies Can Minimize Energy Costs
Via CannabisNewsWire
Topics Cannabis Climate Change
Exposures Cannabis Climate
XPhyto Pursues Market Access in Israel for its COVID-19 PCR Rapid Test
- XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval - Potential customers include government institutions, private healthcare... 
From XPhyto Therapeutics Corp.
Via AccessWire
Topics Cannabis
Exposures COVID-19 Cannabis
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.